Summarized by Masters of Longevity from Longevity Technology.
A profile piece on a Macau university team's scientific approach combining tRNA epigenetics and traditional Chinese medicine screening to pursue longevity solutions. It previews the research strategy, competitive context, and next steps toward clinical validation.
Key Takeaways
- The RETRO-EPIGERNA team from Macau University of Science and Technology won a $1 million Milestone 2 award and advanced to the XPRIZE finals.
- The team built a platform linking tRNA chemical tag changes to aging and screened TCM ingredients to develop a longevity product.
- The university reported p16/p21-related aging markers fell by 40%–60% in clinical trials, but trial size and publication details were not disclosed.
